SURGALIGN HOLDINGS, INC.: Nasdaq/NYSE listing notice — Surgalign receives Nasdaq MVPHS deficiency notice; 180 days to comply

SURGALIGN HOLDINGS, INC.

June 5, 2023: Nasdaq notified SRGA MVPHS fell below $15M for 30 consecutive business days.
Company has until Dec 4, 2023 to regain compliance by closing at $15M+ for 10 consecutive days.
Prior stockholders' equity deficiency (April 10) resolved; Staff closed matter on May 25 plan review.
Failure to regain MVPHS compliance could lead to delisting or transfer to Nasdaq Capital Market.

item 3.01 item 8.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

SURGALIGN HOLDINGS, INC. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(3)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(3)(C)

Exact text from the filing

June 5, 2023 Surgalign Holdings, Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (the “Nasdaq”) notifying the Company that it did not comply with Listing Rule 5450(b)(3)(C) that requires listed securities to maintain a minimum Market Value of Publicly Held Shares (“MVPHS”) of $15,000,000 for 30 consecutive business days. The Nasdaq deficiency letter has no immediate effect on the listing of the Company’s common stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(D), the Company has been given

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-23-164346

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.